BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2182452)

  • 1. BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.
    Henze G; Fengler R; Hartmann R; Niethammer D; Schellong G; Riehm H
    Haematol Blood Transfus; 1990; 33():619-26. PubMed ID: 2182452
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of initial CNS involvement in acute lymphoblastic leukemia childhood.
    Dörffel W; Zintl F; Malke H; Reuter G; Reimann M
    Haematol Blood Transfus; 1990; 33():494-9. PubMed ID: 2182443
    [No Abstract]   [Full Text] [Related]  

  • 3. Results and significance of six randomized trials in four consecutive ALL-BFM studies.
    Riehm H; Gadner H; Henze G; Kornhuber B; Lampert F; Niethammer D; Reiter A; Schellong G
    Haematol Blood Transfus; 1990; 33():439-50. PubMed ID: 2182435
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of relapsed acute lymphocytic leukemia in adults.
    Freund M; De Boben M; Diedrich H; Ganser A; Heil G; Heyll A; Henke M; Hiddemann W; Knauf U; Koch P
    Haematol Blood Transfus; 1990; 33():432-6. PubMed ID: 2182434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.
    Fengler R; Hartmann R; Bode U; Janka G; Jürgens H; Riehm H; Henze G
    Haematol Blood Transfus; 1990; 33():511-5. PubMed ID: 2182445
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987.
    Zintl F; Malke H; Reimann M; Dörffel W; Domula M; Eggers G; Exadaktylos P; Kotte W; Krause I; Kunert W
    Haematol Blood Transfus; 1990; 33():478-82. PubMed ID: 2182440
    [No Abstract]   [Full Text] [Related]  

  • 7. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
    Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J
    Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of acute lymphoblastic leukemia: protocol Fralle 83-85.
    Schaison G; Olive D; Leverger G; Vannier JP; de Lumley L; Bancillon A; Cornu G
    Haematol Blood Transfus; 1990; 33():467-72. PubMed ID: 2182438
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent low-dose central nervous system radiation for high-risk pediatric leukemia patients: preliminary results.
    Belasco JB; Rate W; Mancini A; Paolucci G; Frezza G; Rosito P; Vecchi V; D'Angio GJ
    Med Pediatr Oncol; 1991; 19(2):106-9. PubMed ID: 2011094
    [No Abstract]   [Full Text] [Related]  

  • 10. Biology and therapy of childhood acute lymphoblastic leukemia.
    Rivera GK; Crist WM; Sallan SE
    Rev Invest Clin; 1994 Apr; Suppl():26-33. PubMed ID: 7886304
    [No Abstract]   [Full Text] [Related]  

  • 11. Adult acute leukemia.
    Hoelzer D; Büchner T; Gale RP; Zittoun R
    Rev Invest Clin; 1994 Apr; Suppl():21-5. PubMed ID: 7886303
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.
    Henze G; Fengler R; Reiter A; Ritter J; Riehm H
    Haematol Blood Transfus; 1990; 33():483-8. PubMed ID: 2182441
    [No Abstract]   [Full Text] [Related]  

  • 13. More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.
    Sallan SE; Gelber RD; Kimball V; Donnelly M; Cohen HJ
    Haematol Blood Transfus; 1990; 33():459-66. PubMed ID: 2182437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramedullary spinal cord metastasis of acute lymphoblastic leukemia as the initial manifestation of relapse.
    Kim W; Min CK; Shim YS; Shon YM; Yang DW
    Leuk Lymphoma; 2008 Jun; 49(6):1214-6. PubMed ID: 18569642
    [No Abstract]   [Full Text] [Related]  

  • 16. Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials.
    Bührer C; Henze G; Hofmann J; Reiter A; Schellong G; Riehm H
    Haematol Blood Transfus; 1990; 33():500-3. PubMed ID: 2182444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia.
    Henze G; Fengler R; Hartmann R; Dopfer R; Göbel U; Graf N; Jürgens H; Niethammer D; Ritter J; Schellong G
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S16-9. PubMed ID: 2667787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
    Henze G; v Stackelberg A; Eckert C
    Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia.
    Bührer C; Hartmann R; Fengler R; Dopfer R; Gadner H; Gerein V; Göbel U; Reiter A; Ritter J; Henze G
    Med Pediatr Oncol; 1993; 21(7):470-6. PubMed ID: 8341213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988).
    Veerman AJ; Hählen K; Kamps WA; Vanleeuwen EF; de Vaan GA; Vanwering ER; Vanderdoes-Vandenberg A; Solbu G; Suciu S
    Haematol Blood Transfus; 1990; 33():473-7. PubMed ID: 2182439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.